Assaulting Strong Drug Patents - Global Health Council, January 2005

Excerpt: In recent years, generic drug companies located in India and other developing markets have launched an all-out assault on the drug patent system that locks them out of the most lucrative first-world markets. What they have not achieved in their science labs and their manufacturing floors they hope to make up in the courtrooms, in the press, and inside the halls of the World Health Organization (WHO).